1.
Elahian,
F., Sepehrizadeh, Z., Moghimi, B., Mirzaei, S.A.
Human
cytochrome b5 reductase: Structure, function, and potential applications. Critical
Reviews in Biotechnology 2014, 34(2), pp. 134-143.
2.
Elahian,
F., Reiisi, S., Shahidi, A., Mirzaei, S.A. High-throughput bioaccumulation,
biotransformation, and production of silver and selenium nanoparticles using
genetically engineered Pichia pastoris. Nanomedicine: Nanotechnology, Biology,
and Medicine 2017, 13(3), pp. 853-861.
3.
Elahian,
F., Kalalinia, F., Behravan, J. Dexamethasone
downregulates BCRP mRNA and protein expression in breast cancer cell lines. Oncology
Research 2009, 18(1), pp. 9-15.
4.
Gholamian
Dehkordi, N., Elahian, F., Khosravian, P., Mirzaei, S.A. Intelligent TAT-coupled anti-HER2
immunoliposomes knock downed MDR1 to produce chemosensitize phenotype of
multidrug resistant carcinoma. Journal of Cellular Physiology 2019, 234(11),
pp. 20769-20778.
5.
Elahian,
F., Heidari, R., Charghan, V.R., Asadbeik, E., Mirzaei, S.A. Genetically
modified Pichia pastoris, a powerful resistant factory for gold and palladium
bioleaching and nanostructure heavy metal biosynthesis. Artificial Cells,
Nanomedicine and Biotechnology 2020, 48(1), pp. 259-265.